An article in Fast Company's Co.EXIST discusses the LMRT's cancer-detecting synthetic biomarker technology. The article, which features Dr. Bhatia's November TEDMED talk, highlight's the technology's potential utility in clinical decisionmaking, monitoring patients, and detecting cancers early.

See the full article here.